PhRMA To Assist Pay-For-Locate Trial Enrollment Tool To Boost Study Diversity
This article was originally published in The Pink Sheet Daily
PhRMA takes an active role in shaping a new National Clinical Trial Network that aims to speed up enrollment of diverse study populations as FDA increases its push for minorities in clinical research.
You may also be interested in...
Extension of the Clinical Trial Engagement Network is aimed at increased diversity in clinical trials, which is becoming increasingly important as more drugs are targeted at specific groups.
Bull returns to the agency after stints at Novartis and Genentech to become director of the Office of Minority Health.
Vertex Pharmaceuticals' Incivek (telaprevir) has cleared FDA with labeling advantages that should enable it to win a majority of patients in the battle against Merck's competing protease inhibitor for hepatitis C, Victrelis (boceprevir).